Bassem Al Hariri | Health Professions | Best Researcher Award

Posted on by Shen Awards

Assist. Prof. Dr.  Bassem Al Hariri | Health Professions | Best Researcher Award

Assist. Prof. Dr. from Hamad Medical corporation, Qatar

Dr. Bassem Naif Altaleb Alhariri is a distinguished specialist in Internal Medicine and Pulmonary Diseases with extensive experience in clinical practice, medical education, and research. He is currently a Consultant in Internal Medicine & Pulmonology at Hamad Medical Corporation’s Hazm Mebaireek General Hospital in Qatar. Born in Syria on November 1, 1977, Dr. Alhariri has dedicated his career to providing high-quality medical care, mentoring young professionals, and contributing to research in his field. His expertise spans respiratory disorders, emergency medicine, and intensive care, along with a strong background in academic training and committee leadership. With multiple board certifications and international medical licensure, he has made significant contributions to internal medicine and pulmonology.

Professional Profile

Education

Dr. Alhariri earned his MD in General Medicine from Damascus University in 2004. He pursued a specialization in Internal Medicine, receiving his certification from the Syrian Ministry of Health in 2009. Furthering his expertise, he completed a specialization in Pulmonary Diseases in 2013. His postgraduate training included rigorous residency programs at Damascus’s top university hospitals, providing extensive exposure to various medical subspecialties. He holds board certifications in both Internal Medicine and Pulmonary Diseases from the Syrian Board, demonstrating his commitment to excellence in patient care and medical practice.

Professional Experience

Dr. Alhariri has amassed a wealth of experience across multiple medical institutions. He began his career in Syria, serving as a Senior Specialist in Internal Medicine at several government hospitals, later becoming the Head of Department at Izraa Hospital. From 2013 to 2016, he worked as a Consultant in Internal Medicine and Pulmonology, including humanitarian efforts with the International Medical Corps. Since 2017, he has been practicing in Qatar, first at a polyclinic and later at Hamad Medical Corporation. His expertise includes emergency care, intensive care unit (ICU) management, outpatient pulmonary services, and complex diagnostic procedures such as bronchoscopy, thoracoscopy, and lung biopsies.

Research Interests

Dr. Alhariri is deeply involved in medical research, focusing on respiratory disorders, critical care, and emerging treatments in pulmonology. His work includes studying innovative diagnostic techniques and therapeutic approaches for chronic respiratory diseases. As a member of Hamad Medical Corporation’s research committee, he actively contributes to clinical studies and the advancement of evidence-based medicine. His research interests align with improving patient outcomes through novel interventions, medical education strategies, and the integration of advanced diagnostic tools in pulmonary medicine.

Research Skills

Dr. Alhariri possesses strong research skills in clinical case analysis, medical data interpretation, and systematic reviews. His expertise extends to conducting hospital-based research, analyzing patient outcomes, and developing treatment protocols for respiratory conditions. As a reviewer for Clinical Case Reports Journal (Wiley), he critically evaluates medical research publications. His research methodology includes case-control studies, cohort analyses, and qualitative assessments of medical interventions. His ability to integrate clinical practice with research enhances his role as both a physician and an academic mentor.

Awards and Honors

Dr. Alhariri has been recognized for his contributions to medical education, clinical excellence, and research. He has served as an examiner for the Objective-Structured Clinical Exam (OSCE) at Qatar University and as a faculty member at Weill Cornell Medicine-Qatar. His leadership roles include membership in the Clinical Practice Guidelines (CPG) committee and education committees at Hamad Medical Corporation. His dedication to teaching has earned him appointments as a clinical lecturer at Qatar University and an assistant professor at Weill Cornell Medicine-Qatar. These honors reflect his commitment to fostering the next generation of medical professionals.

Conclusion

Dr. Bassem Naif Altaleb Alhariri is a highly accomplished medical professional with a deep passion for patient care, medical education, and research. His extensive experience in internal medicine and pulmonology, combined with his active role in academic training and clinical research, has positioned him as a key contributor to the field. With his unwavering dedication to medical excellence, Dr. Alhariri continues to impact healthcare in Qatar and beyond, shaping the future of respiratory medicine and mentoring aspiring physicians. His commitment to lifelong learning and innovation makes him a respected leader in his specialty.

Publications Top Notes

  1. Case of severe thrombocytopenia with recurrent extensive deep vein thrombosis due to antiphospholipid syndrome, management challenge

    • Authors: Bassem Al Hariri, Gaydaa Ali Ahmed Ali, Arwa Elfatih Mohamed Ali, Mohamed Elfatih MohamedAli, Feroz Jenner Poolakundan, Muhammad Sharif, Memon Noor Illahi
    • Year: 2025

  2. A rare case presentation of gastrointestinal stromal tumor (GIST) in a young adult patient

    • Authors: Bassem Al Hariri, Rawan S. Mohamed, Hadil Altaj Altrify Alsidig, Abdulqadir J. Nashwan, Muad Abdi Hassan
    • Year: 2024

  3. An adolescent presenting with Caroli syndrome associated with polycystic kidney disease: A case report

    • Authors: Bassem Al Hariri, Vajeeha Haider, Memon Noor Illahi, Muhammad Sharif, Abdulqadir J. Nashwan
    • Year: 2024

  4. An idiopathic severe macroglossia in a young adult patient: a rare case

    • Authors: Bassem Al Hariri, Muad A. Hassan, Muhammad Sharif, Rawan S. Mohamed, Hadil A. A. Alsidig, Hadil A. A. Alsiddig, Memon N. Illahi
    • Year: 2024

  5. Brucellosis an Unusual presentation as isolated septic mono-arthritis of the knee joint: A case report

    • Authors: Muad A. Hassan, F. Noor, A. Salehi, Bassem Al Hariri
    • Year: 2024

  6. Correction to “Spontaneous hemothorax caused by rivaroxaban treatment for pulmonary embolism: a case report.”

    • Authors: Bassem Al Hariri, A. Alharafsheh, M. A. Hassan, A. J. Nashwan, M. G. Mohamedali, H. M. Abusriwil
    • Year: 2024

  7. Effect of pioglitazone on inflammatory response and clinical outcome in T2DM patients with COVID-19: a randomized multicenter double-blind clinical trial

    • Authors: K. Baagar, T. Alessa, M. Abu-Farha, J. Abubaker, H. Alhumaidi, J.A. Franco Ceruto, M.K. Hamad, A. Omrani, S. Abdelrahman, M. Zaka-Ul Haq, et al.
    • Year: 2024

  8. Periodic Paralysis: A Case Series with a Literature Review

    • Authors: Bassem Al Hariri, Muad A. Hassan, Muhammad Sharif, O. A. Alsakaji, Y. A. Hassan, M. K. Khalid
    • Year: 2024

  9. Streptococcus cristatus: An uncommon cause for a common hospital admission

    • Authors: U. Al-Anbagi, A. Salehi, G. J. Wilson, F. Noor, A. O. Mohamed, A. Haji, A. J. Nashwan, H. A. Nasir, Bassem A. Hariri
    • Year: 2024

  10. Unusual isolated splenic hydatid cyst: A case report

  • Authors: Bassem Al Hariri, Vajeeha Haider, Mamunul Islam, Abdalrahman Mohammed Mostafa, Ahmad Eid Nazzal Alharafsheh, Memon Noor Illahi
  • Year: 2024

 

Dirk Keiner | Health Professions | Innovation Excellence Award

Posted on by Shen Awards

Dr. Dirk Keiner | Health Professions | Innovation Excellence Award

Pharmacist at Sophien and Hufeland Clinic Weimar, Germany

Dirk Richard Keiner is an accomplished clinical pharmacist with significant contributions to the advancement of medication safety and clinical pharmacy practice. He is the Head of the Pharmacy at the Sophien- und Hufeland-Klinikum Weimar and holds leadership roles in several professional organizations, including the ADKA Thüringen and G³ – Arbeitsgemeinschaft für moderne Medizin e.V. Keiner has also been deeply involved in education, serving as a lecturer at various institutions such as the SRH University of Health and University of Jena. His innovative research focuses on improving drug therapy management, particularly in geriatrics, oncology, and medication safety. With a vast publication record, numerous awards, and a long-standing commitment to advancing clinical pharmacy, Keiner is a recognized leader in his field.

Professional Profile

Education:

Keiner completed his pharmaceutical studies at the Ernst-Moritz-Arndt University of Greifswald, where he graduated with a degree in Pharmacy in 1996. He conducted his diploma thesis on the analysis of valerian root essential oil. Keiner further pursued a doctorate at the Humboldt University Berlin, earning a Dr. rer. nat. with magna cum laude in 2006. His doctoral research compared various instruments used to measure the quality of life in osteoporosis patients. His strong educational foundation is complemented by various advanced professional qualifications, including specialization in Clinical Pharmacy.

Professional Experience:

Keiner’s career spans multiple leadership roles in both pharmacy practice and academia. He currently serves as the Head of the Pharmacy at the Sophien- und Hufeland-Klinikum Weimar, a position he has held since 2017. Prior to this, he led the pharmacy at SRH Zentralklinikum Suhl and Waldkrankenhaus Eisenberg. His experience also includes extensive work in hospital and community pharmacies. Keiner has been actively involved in professional organizations, including serving as a board member of the ADKA Thüringen and as a delegate in the LAK Thüringen. His diverse professional background showcases his commitment to improving clinical pharmacy and patient care.

Research Interests:

Keiner’s research interests lie primarily in the area of medication safety, particularly in improving drug therapy management for older adults and cancer patients. He focuses on addressing gender-specific aspects of medication therapy and exploring the impact of drug-sun interactions. His work also extends to the development of tools for preventing medication errors and optimizing patient outcomes in clinical settings. Keiner’s research aims to bridge gaps in clinical pharmacy by tackling real-world challenges, such as the safe use of medications in vulnerable populations and the integration of new technologies into clinical practice.

Research Skills:

Keiner’s research skills are rooted in his extensive clinical pharmacy expertise, particularly in medication therapy management and safety. He is adept at conducting in-depth analyses of pharmaceutical interventions, particularly in geriatrics and oncology. Keiner employs various research methodologies, including qualitative and quantitative approaches, to assess the efficacy of drug therapy and the risks associated with certain medications. His ability to translate research findings into practical clinical applications is a hallmark of his work. Moreover, Keiner is skilled in evaluating and improving patient outcomes through the design and implementation of clinical studies that focus on medication errors and therapeutic optimization.

Awards and Honors:

Keiner’s exceptional contributions to clinical pharmacy have earned him numerous prestigious awards. Notable recognitions include the Sanofi-Synthelabo Prize for innovative work in clinical pharmacy, the Authors’ Prize from Krankenhauspharmazie, and the 1st place in the “Patient-Oriented Services” competition by the Dr. Hellmuth-Häussermann Foundation. In 2024, he received the ADKA Innovation Prize for his work on medication safety in the clinical setting. These accolades highlight his dedication to improving patient safety and advancing the field of clinical pharmacy. Keiner’s awards reflect his significant impact on both the scientific community and the practical application of pharmacy in healthcare settings.

Conclusion:

Dirk Richard Keiner’s career exemplifies innovation in clinical pharmacy, with a focus on improving medication safety and therapy management. His strong track record of leadership, research, and education, coupled with several prestigious awards, positions him as a deserving candidate for the Research for Innovation Excellence Award. While there are opportunities for expanding the global and interdisciplinary reach of his work, his contributions to the field of clinical pharmacy are significant, and his leadership in research and education make him a standout nominee.

Publication Top Notes

  1. AMTS Risk Profile Abiraterone | AMTS-Risk profile Abiraterone
    • Authors: Keiner, D.
    • Journal : M
    • Year: 2024
    • Volume: 47(3), pp. 106–114
  2. I’m Sorry, What? | Wie Bitte?
    • Authors: Keiner, D., Hoffmann, K.
    • Journal: Deutsche Apotheker Zeitung
    • Year: 2024
    • Volume: 2024(9)
  3. Probiotics & Co. – What Is Guaranteed? | Probiotics & Co. – What Is Guaranteed?
    • Authors : Keiner, D.
    • Journal: Medizinische Monatsschrift für Pharmazeuten
    • Year: 2023
    • Volume: 46(12)
  4. AMTS Risk Profile Apixaban | AMTS Risk Profile Apixaban
    • Authors : Kei
    • Journal : M
    • Year: 2023
    • Volume: 46(9), pp. 319–326
  5. Check-Change-Control: Management Aspects of Arterial Hypertension in Geriatric Patients | Management Aspects of Arterial Hypertension in Geriatric Patients
    • Authors: Keiner, D., Gockel, H.
    • Journal: Medizinische Monatsschrift für Pharmazeuten
    • Year: 2023
    • Volume: 46(4), pp. 114–123
  6. Risk Pyramid Allopurinol | AMTS-Risk profile Allopurinol
    • Authors: Keiner, D.
    • Journal: Medizinische Monatsschrift für Pharmazeuten
    • Year: 2023
    • Volume: 46(1), pp. 12–19
  7. Much Helps Much – Or Is It? | Much Helps Much – Or Is It Not?
    • Authors: Keiner, D., Picksak, G.
    • Journal : Kr
    • Year: 2022
    • Volume: 43(9), pp. 375–376
  8. Gender-Specific Aspects of Cancer Management – ​​Ready for the Future? | Gender-Specific Aspects in Oncology Care – Ready for the Future?
    • Authors : Ke
    • Journal: Krankenhauspharmazie
    • Year: 2022
    • Volume: 43(9), pp. 353–362
  9. Gender-Specific Aspects of Drug Therapy – The New Clinical Challenge? | Gender-Specific Aspects of Drug Therapy: The New Clinical Challenge?
    • Authors: Keiner, D.
    • Journal: Krankenhauspharmazie
    • Year: 2022
    • Volume: 43(9), pp. 363–366
  10. Gender-Sensitive Medication Management | Gender-Sensitive Medication Management
    • Authors : None,
    • Journal : M
    • Year: 2022
    • Volume: 45(8), pp. 312–314

 

 

Saeid Ferdousmakan | Health Professions | Best Researcher Award

Posted on by Shen Awards

Dr. Saeid Ferdousmakan | Health Professions | Best Researcher Award

Researcher at Nargund College of Pharmacy, Iran

Saied Ferdousmakan is a dedicated clinical pharmacist and researcher with a strong background in oncology, pharmacology, and medication safety. He earned his Doctor of Pharmacy (PharmD) degree from Rajiv Gandhi University of Health Sciences, Bengaluru, India, where he focused on medication safety in obstetrics and gynecology. His research interests are centered on miRNA-based therapeutic strategies for cancer, particularly liver cancer and melanoma, as well as autophagy mechanisms and immunotherapies. Saied’s expertise is further enhanced by practical experience as a clinical pharmacist, having worked in both India and Iran. He is committed to advancing cancer research and therapeutic interventions, actively contributing to scientific literature through publications and conference presentations. Saied is also engaged in continuous professional development, attending workshops on topics like molecular biology, immunoinformatics, and oncology. His soft skills in leadership, communication, and public speaking add to his overall capability as a researcher and healthcare professional.

Professional Profile

Education:

Saied Ferdousmakan holds a Doctor of Pharmacy (PharmD) degree from Rajiv Gandhi University of Health Sciences in Bengaluru, India, where he completed his studies from July 2013 to May 2019. His academic journey was marked by a focus on pharmacy, where he earned a GPA of 2870 out of 4500, recognized as a first division. His PharmD thesis, titled Medication Safety in Obstetrics and Gynecology Ward in Jayanagar General Hospital, Bangalore, highlighted his commitment to improving healthcare practices. His education laid the foundation for his ongoing research in therapeutic strategies and clinical pharmacy.

Professional Experience:

Saied’s professional career spans clinical pharmacy and research. From January 2023 to March 2024, he worked as a Clinical Pharmacist at Daryan Hospital in Iran, where he provided direct patient care and contributed to medication management. Prior to this, he completed an internship at Jayanagar General Hospital in India from July 2019 to July 2020. His role involved enhancing patient care and improving safety protocols in the hospital’s general medicine department. This clinical experience has strengthened his practical understanding of drug therapy, which complements his research focus.

Research Interests:

Saied Ferdousmakan’s primary research interests lie in the design and application of miRNA-based therapies for cancer, with a special focus on liver cancer. His work investigates miR-148a-3p as a negative regulator of glycometabolism and cell proliferation in liver cancer cells. Additionally, he explores the role of Ambra1 protein in autophagy, which contributes to drug resistance and cancer progression, particularly in melanoma. Saied is also involved in studying immunotherapies targeting CTLA-4 and PD-1 in melanoma, as well as developing inhibitors like PKC and C-Met for treating uveal melanoma. His interest extends to stem cell research and using NOV/CCN3 proteins to enhance hematopoietic stem cell function, particularly in cord blood units.

Research Skills:

Saied possesses strong research skills in molecular biology, immunotherapy, and pharmacology. His expertise in designing miRNA-based therapeutic strategies and his understanding of cancer biology, particularly in melanoma and liver cancer, reflect his solid foundation in experimental design. He is proficient in laboratory techniques such as PCR, cell culture, and Western blotting, which are crucial for his studies in autophagy and drug resistance. Additionally, Saied is skilled in statistical analysis and the use of bioinformatics tools like R for analyzing complex datasets. His involvement in international research conferences further attests to his ability to communicate complex scientific findings to diverse audiences.

Awards and Honors:

While specific awards and honors are not explicitly listed, Saied has made significant contributions to research and academia, as evidenced by his publications in reputable journals such as Cancer Cell International and Pak. J. Med. Health Sci., as well as his presentations at international conferences. His ongoing research in cancer treatment and medication safety has been well-received in academic circles. Additionally, his active participation in professional workshops and continuous learning showcases his commitment to personal and professional growth. These factors, combined with his practical work experience and leadership abilities, suggest that Saied is on track for future recognition in his field.

Conclusion

Saied Ferdousmakan presents a strong candidacy for the Best Researcher Award based on his impactful research focus in oncology, a solid record of publications and presentations, and practical experience in clinical settings. His commitment to continuous education through specialized workshops and his exceptional soft skills contribute positively to his profile. Expanding his technical expertise and range of published research would further enhance his credentials. Overall, Saied is a promising researcher with substantial potential to make meaningful contributions to pharmacology and oncology.

Publication Top Notes

  1. Current understanding of epigenetics role in melanoma treatment and resistance
    • Authors: M Karami Fath, A Azargoonjahromi, A Soofi, F Almasi, S Hosseinzadeh, …
    • Year: 2022
    • Citation Count: 35
    • Source: Cancer Cell International, 22(1), 313
  2. Reactive oxygen species induced by SARS-CoV-2 infection can induce EMT in solid tumors: potential role of COVID-19 in chemo-resistance and metastasis
    • Authors: M Moulaeian, S Ferdousmakan, S Banihashemi, S Homayounfar, …
    • Year: 2024
  3. Evaluation of pulmonary bacterial infections in people exposed to mustard gas
    • Authors: SM Fathi, Farzam Nasirzadeh, Zahra, Ferdousmakan, Saeid, …
    • Year: 2022
  4. Medication Safety in Obstetrics and Gynecology Ward in Jayanagar General Hospital, Bangalore, India
    • Authors: S Ferdousmakan, N KB, M Etesami
    • Year: 2021
    • Source: Pakistan Journal of Medical and Health Sciences, 15(5), 1270-1275
  5. Medication Safety in Obstetrics and Gynecology Ward in Tertiary Care Hospital, Bangalore, India
    • Authors: M Etesami, S Sirisha, S Ferdousmakan
    • Year: 2020
    • Source: Archives of Pharmacy Practice, 11(1-2020), 81-86
  6. Evaluation of Herpes Simplex Virus Types 1 and 2 in Patients with Multiple Sclerosis
    • Authors: SF Shahkamali, SMG Dazmiri, N Amirebrahimi
    • Year: Not specified

 

Lomanono Ngidie | Nursing and Health Professions | Best Researcher Award

Posted on by Shen Awards

Ms. Lomanono Ngidie | Nursing and Health Professions | Best Researcher Award

Registered Nurse at University of Zambia, Eswatini (Swaziland)

Lomanono Ngidie is a dedicated healthcare professional based in Eswatini, specializing in nursing and public health. With a strong commitment to improving healthcare access, particularly in the field of HIV care, Lomanono has cultivated a rich blend of clinical and academic expertise. She is a registered nurse and a focal person for the Antiretroviral Treatment (ART) department at the AIDS Healthcare Foundation. Her efforts focus on managing ART patients and enhancing the quality of care provided in underserved communities. Lomanono holds a profound belief in the power of education and research to drive change in healthcare practices. A fluent speaker of both SiSwati and English, she is known for her collaborative spirit and ability to work effectively with diverse populations. Lomanono aims to influence healthcare policies and improve patient outcomes through her ongoing research and clinical initiatives.

Professional Profile

Education

Lomanono Ngidie is currently pursuing a Master of Science in Nursing with a specialty in Clinical Nursing at the University of Zambia, expected to be completed in 2024. She previously earned her Bachelor of Nursing Science degree, majoring in Midwifery Science, from the University of Eswatini in 2018. To enhance her practical skills, Lomanono has undertaken various specialized training programs, including NARTIS (Nurse-led ART Initiation), IMAI (Integrated Management of Adult and Adolescent Illnesses), and a comprehensive care package for key populations, all conducted by the Eswatini Ministry of Health. Additionally, she holds a certificate in HIV Testing and Counseling from Population Services International (PSI). Her educational journey reflects her commitment to acquiring knowledge and skills that directly benefit her community, equipping her to address pressing health challenges effectively.

Professional Experience

Lomanono Ngidie has amassed over five years of clinical experience in the nursing field, primarily focusing on HIV care and management. Since 2019, she has served as a registered nurse and ART department focal person at the AIDS Healthcare Foundation in Matsapha, Eswatini. In this role, she manages ART patients, conducts cervical cancer screenings, and provides primary healthcare services. Lomanono previously worked as a registered nurse at the Community Health Intervention Programme (CHIPS), where she honed her clinical skills. Her responsibilities have also included tracking performance benchmarks, report writing, and initiating quality improvement projects aimed at enhancing healthcare delivery. Her extensive experience in community nursing, coupled with her hands-on approach to patient care, positions her as a valuable asset in the healthcare system and demonstrates her commitment to improving health outcomes for vulnerable populations.

Research Interest

Lomanono Ngidie is particularly interested in public health research focusing on HIV care and management. Her current research project investigates the predictors of late presentation for HIV care among adults at the AIDS Healthcare Foundation Clinic in Matsapha, aiming to identify barriers that prevent timely access to treatment. This research is critical, as early initiation of ART significantly improves patient outcomes and reduces transmission rates. Lomanono’s interest extends to exploring strategies for enhancing patient engagement, reducing stigma, and improving healthcare access for marginalized populations. She believes that understanding the sociocultural factors influencing healthcare behavior is vital for developing effective interventions. Her dedication to evidence-based practice drives her research pursuits, as she strives to translate findings into actionable improvements in clinical care and public health policies.

Awards and Honors

While specific awards and honors are not explicitly mentioned in Lomanono Ngidie’s CV, her commitment to excellence in nursing and public health has likely garnered recognition within her professional community. Lomanono’s involvement in quality improvement projects and successful management of ART patients exemplifies her dedication to improving healthcare delivery. Her ongoing research efforts, particularly her manuscript under review in an international journal, reflect her ambition and potential to contribute meaningfully to the field. She is supported by strong references from experienced professionals in healthcare, which further underscores her reputation and capability. As she continues her academic and professional journey, Lomanono is poised to receive recognition for her contributions to nursing and public health in Eswatini and beyond, reflecting her dedication to improving health outcomes for vulnerable populations.

Conclusion

Lomanono Ngidie is a strong candidate for the Best Researcher Award due to her relevant educational background, extensive clinical experience, and a proactive approach to research. Her ongoing work in the field of HIV care is particularly commendable, as it addresses a critical health issue in her community. While there are areas for improvement, such as increasing her publication record and broadening her research experiences, her current achievements and skills position her as a promising researcher with the potential to make significant contributions to the field of nursing and public health. With continued growth and development, Lomanono has the capability to be a leading figure in healthcare research in Eswatini and beyond.

Publication top noted

  • Title: Predictors of late presentation for HIV care among adults at AIDS Healthcare Foundation clinic in Matsapha, Manzini Region, Eswatini 🏥
  • Authors: Lomanono N. Ngidie, Ruth Wahila, Phadaless Sinkamba 👩‍⚕️👩‍⚕️👨‍⚕️
  • Journal: International Journal of Africa Nursing Sciences 📖
  • Year: 2024 🗓️
  • Publication Date: October 2024 📅
  • DOI: 10.1016/j.ijans.2024.100788 🔗

SILESHI MULATU | Health Professions | Best Researcher Award

Posted on by Shen Awards

Mr. SILESHI MULATU | Health Professions | Best Researcher Award

Assistant Professor at Bahir Dar University College of medicine and health science, Ethiopia.

Sileshi Mulatu Tafere is an Assistant Professor of Pediatrics and Child Health Nursing at Bahir Dar University College of Medicine and Health Sciences, with over 13 years of academic and administrative experience. He holds a BSc from Alkan University College and an MSc from the University of Gondar. His professional journey includes roles as an Assistant GA, Assistant Lecturer, and Lecturer at various health science colleges. He is actively involved in teaching, research, and supervising students at both undergraduate and postgraduate levels. Sileshi has published numerous research articles in reputable journals, focusing on topics like dietary diversity, medication adherence, and health interventions. He has also contributed to community service initiatives and curriculum development. With strengths in teamwork, communication, and project management, Sileshi demonstrates a commitment to advancing pediatric nursing and public health. His dedication to research and education positions him as a strong candidate for recognition as a leading researcher.

Profile:

Education

Sileshi Mulatu Tafere holds a Bachelor of Science degree in Nursing from Alkan University College, which he completed on August 1, 2011. He further pursued advanced studies and earned a Master of Science in Pediatrics and Child Health Nursing from the University of Gondar on July 3, 2016. His academic journey is marked by a commitment to understanding pediatric healthcare, which he has translated into both his teaching and research roles. Throughout his educational pursuits, Sileshi has developed a strong foundation in nursing principles, emphasizing the importance of child health and development. His dedication to continuous learning is evident in his ongoing professional development, as he actively seeks to enhance his expertise in the field. This educational background not only qualifies him for his current role as an Assistant Professor at Bahir Dar University College of Medicine and Health Sciences but also informs his research endeavors in pediatrics and public health.

Professional Experiences 

Sileshi Mulatu Tafere is an Assistant Professor of Pediatrics and Child Health Nursing at Bahir Dar University College of Medicine and Health Sciences, bringing over 13 years of academic and administrative experience. He has served in various roles, including Assistant Lecturer and Lecturer at Pawie Health Science College and Bahir Dar University. His responsibilities encompass teaching, module development, and conducting research on public health issues, particularly co-infections at Pawie Hospital. He has chaired the Neonatal Nursing Module Course and actively supervises both undergraduate and postgraduate students. Sileshi is involved in several committees focused on curriculum revision and quality assurance. He also leads community service initiatives, providing training on first aid, infection prevention, and medication administration to health professionals and students. His commitment to education and community service is evident in his efforts to enhance nursing practices and address public health challenges in Ethiopia.

Research Interests

Sileshi Mulatu Tafere’s research interests primarily focus on pediatrics and child health nursing, addressing critical public health issues in Ethiopia. His work encompasses dietary diversity and its impact on the health of lactating women and children, as evidenced by his systematic reviews and meta-analyses. Sileshi is particularly invested in understanding the factors influencing medication adherence among asthmatic patients and the predictors of prolonged hospitalization in children with severe pneumonia. He is also dedicated to investigating community health challenges, such as enteric infections and drug-resistant bacteria, through community-based research and training programs. His commitment to improving neonatal care is reflected in his research on enteral feeding practices in neonates. Additionally, Sileshi’s interest in education extends to curriculum development and effective teaching strategies in nursing, aiming to enhance the competencies of healthcare professionals in Ethiopia. Overall, his multifaceted research agenda seeks to contribute significantly to improving child health outcomes and healthcare practices in his community.

Research skills 

Sileshi Mulatu Tafere possesses a robust set of research skills that significantly contribute to his effectiveness as an Assistant Professor in Pediatrics and Child Health Nursing. His expertise includes designing and conducting community-based studies, evidenced by his published work on dietary diversity and health outcomes among specific populations in Ethiopia. Sileshi has demonstrated proficiency in statistical analysis and data handling using various software, enhancing the quality and reliability of his research findings. His experience in curriculum development and module creation reflects his ability to integrate research into academic frameworks. Additionally, Sileshi’s collaborative nature is highlighted through his involvement in multiple multidisciplinary projects, fostering a team-oriented approach to research. He actively supervises undergraduate and postgraduate students, equipping them with research methodologies and critical thinking skills. Sileshi’s commitment to continuous learning and staying updated on health-related advancements further strengthens his research capabilities, making him a valuable asset to his academic institution and the broader medical community.

Award and Recognition 

Sileshi Mulatu Tafere has received several accolades and recognitions throughout his career, underscoring his dedication to pediatric and child health nursing. As an Assistant Professor at Bahir Dar University College of Medicine and Health Sciences, he has been instrumental in improving educational outcomes and advancing public health initiatives in Ethiopia. His research contributions, particularly in dietary diversity and neonatal care, have been published in prestigious journals, earning him respect in the academic community. Sileshi’s role as a course chair and mentor for postgraduate students showcases his commitment to nurturing future healthcare professionals. Additionally, his community service initiatives, including training sessions on first aid and infection prevention, have made a significant impact, enhancing health awareness in local communities. These efforts have not only advanced healthcare education but have also contributed to better health outcomes for children and families in the region, earning him recognition as a leading figure in his field.

Conclusion

Sileshi Mulatu Tafere stands out as a strong candidate for the Research for Best Researcher Award, given his extensive experience, impactful research contributions, and commitment to education and community service. While there are areas for improvement, such as enhancing funding strategies and expanding professional networks, his dedication to pediatrics and child health nursing positions him as a leader in the field. Awarding him this recognition would not only acknowledge his contributions but also encourage further advancements in pediatric health research in Ethiopia and beyond.

Publication Top Notes
  1. Mortality and its determinants among patients attending in emergency departments
    • Authors: Messelu, M.A., Amlak, B.T., Mekonnen, G.B., Mulatu, S., Ayenew, T.
    • Year: 2024
    • Journal: BMC Emergency Medicine
    • Volume/Issue/Page: 24(1), 125
  2. Knowledge, practice and associated factors towards intravenous cannula-related infection prevention among nurses working at Northwest Amhara Regional State Comprehensive Specialized Hospitals, Ethiopia
    • Authors: Dessalegn, A., Ali, M.S., Yohannes, S., Mulatu, S., Zewdie, A.
    • Year: 2024
    • Journal: BMC Nursing
    • Volume/Issue/Page: 23(1), 168
  3. The prevalence of asthma and its predictor among patients presenting in Ethiopian public hospitals: systematic review and meta-analysis
    • Authors: Adal, O., Mamo, S.T., Belay, A.E., Tafere, C., Belayneh, A.G.
    • Year: 2024
    • Journal: Therapeutic Advances in Respiratory Disease
    • Volume: 18
  4. Time to Reach Full Enteral Feeding and Its Predictors among Very Low Birth Weight Neonates Admitted in the Neonatal Intensive Care Unit: A Follow-Up Cohort Study
    • Authors: Getahun, B.A., Mulatu, S., Workie, H.M.
    • Year: 2024
    • Journal: Journal of Nutrition and Metabolism
    • Volume: 2024, 9384734
  5. Medication non-adherence and predictor factors among adult asthmatic patients in Ethiopia: a systematic review and meta-analysis
    • Authors: Tafere, C., Bahiru, B., Yehualaw, A., Adal, O., Endeshaw, D.
    • Year: 2024
    • Journal: Journal of Asthma
  6. Community Pharmacists’ Knowledge and Attitude Towards Opioid Pain Medication Use in Bahir Dar City, North-West Ethiopia
    • Authors: Tafere, C., Tefera, B.B., Yehualaw, A., Mulatu, S., Endeshaw, D.
    • Year: 2024
    • Journal: Journal of Multidisciplinary Healthcare
    • Volume/Issue/Page: 17, pp. 833–841
  7. Predictors of prolonged hospitalization among children aged 2–59 months with severe community-acquired pneumonia in public hospitals of Benishangul-Gumuz Region, Ethiopia: a multicenter retrospective follow-up study
    • Authors: Dinku, H., Amare, D., Mulatu, S., Abate, M.D.
    • Year: 2023
    • Journal: Frontiers in Pediatrics
    • Volume/Article ID: 11, 1189155
  8. Magnitude of mortality and its associated factors among burn victim children admitted to South Gondar zone government hospitals, Ethiopia, from 2015 to 2019
    • Authors: Tiruneh, C.M., Belachew, A., Mulatu, S., Belete, A., Walle, B.G.
    • Year: 2022
    • Journal: Italian Journal of Pediatrics
    • Volume/Issue/Page: 48(1), 12
  9. Raw cow milk nutritional content and microbiological quality predictors of South Gondar zone dairy farmers in Ethiopia, 2020
    • Authors: Yenew, C., Tadele, F., Minuye, B., Mulatu, S., Demissie, B.
    • Year: 2022
    • Journal: Heliyon
    • Volume/Issue/Page: 8(10), e11020
  10. Occurrence of drug-resistant enteric bacteria and associated factors among food handlers of the Mass Catering Center: A laboratory-based cross-sectional study
    • Authors: Yenew, C., Andualem, M., Tadele, F., Atikilt, G., Gebeyehu, A.A.
    • Year: 2022
    • Journal: Italian Journal of Food Safety
    • Volume/Issue/Page: 11(3), 10221

 

 

 

Imelda Rocío Guzmán Cervantes | Health Professions | Health Innovator’s Leadership Award

Posted on by Shen Awards

Mrs. Imelda Rocío Guzmán Cervantes | Health Professions | Health Innovator’s Leadership Award

Directora Ejecutiva de Control Analítico at Comisión Federal para la Protección contra Riesgos Sanitarios, Mexico

Mrs. Imelda Rocío Guzmán Cervantes is a highly accomplished professional in pharmaceutical chemistry and public health regulation. With a Master’s degree in Innovation and Technology Management from UNAM, where she earned an Honorable Mention for her thesis on the impact of transnational corporations on the pharmaceutical industry, her academic foundation is robust. She also holds a Bachelor’s degree in Pharmaceutical Chemistry Biology from UNAM, complemented by diplomas in Total Quality Control and Leadership from UPIICSA and Anáhuac University. Currently serving as the Executive Director of Analytical Control at COFEPRIS, Mrs. Guzmán Cervantes plays a pivotal role in overseeing the National Control Laboratory, ensuring the safety of products such as vaccines and medical devices. Her leadership has been instrumental in COFEPRIS’s recognition by WHO and PAHO, and she has actively contributed to international regulatory projects and workshops. Her work, including publications on the role of regulatory agencies during the COVID-19 pandemic, underscores her dedication to enhancing public health safety and regulatory standards.

Profile
Education

Mrs. Imelda Rocío Guzmán Cervantes has a robust educational background that has significantly contributed to her expertise in the fields of pharmaceutical chemistry, quality control, and innovation management. She earned her Master’s degree in Innovation and Technology Management from the Faculty of Chemistry at UNAM, where she received an Honorable Mention for her thesis on the strategies of transnational corporations and their impact on the national pharmaceutical industry. Earlier, she completed her undergraduate studies in Pharmaceutical Chemistry Biology at UNAM, where she engaged in research on the development and implementation of a master plan for validating cleaning processes in pharmaceutical production. Mrs. Guzmán Cervantes has also pursued specialized diplomas in Total Quality Control from UPIICSA and in Leadership and Personal Development from Anáhuac University. Additionally, she completed a graduate program in Management Systems Monitoring Product Safety Market at Universitat Pompeu Fabra in Barcelona, further enhancing her expertise in ensuring product safety in the healthcare sector. Her educational journey reflects a strong commitment to continuous learning and excellence in her field.

Professional Experience

Mrs. Imelda Rocío Guzmán Cervantes has built a distinguished career in pharmaceutical regulation and quality assurance. Since 2009, she has been with COFEPRIS, the Federal Commission for Protection against Sanitary Risk in Mexico, where she currently serves as the Executive Director of Analytical Control. In this role, she leads the National Control Laboratory, overseeing the analysis of vaccines, food, drugs, and medical devices to ensure their safety and efficacy. Her tenure at COFEPRIS includes significant achievements such as facilitating the agency’s recognition as a National Regulatory Authority by WHO and PAHO, and securing WHO prequalification for its laboratory. Prior to her current position, Mrs. Guzmán Cervantes worked as a Technical Advisor to the Commissioner and played a key role in establishing policies and coordinating international relationships. She also gained valuable experience as a Validation Coordinator at Protein S.A. de C.V., where she focused on quality assurance in the pharmaceutical industry. Her extensive experience underscores her commitment to enhancing public health safety and regulatory standards.

Research Interests

Mrs. Imelda Rocío Guzmán Cervantes’s research interests primarily focus on pharmaceutical regulation, quality control, and public health safety. Her work is centered on the development and implementation of regulatory frameworks and methodologies to ensure the safety and efficacy of pharmaceuticals and medical devices. She is particularly interested in the impact of regulatory practices on public health, as demonstrated by her research on the role of national regulatory agencies during the COVID-19 pandemic. Additionally, Mrs. Guzmán Cervantes explores innovations in quality control processes and the integration of international standards into national regulatory practices. Her research aims to advance the effectiveness of regulatory systems and enhance the overall safety of pharmaceutical products and medical devices.

Research Skills

Mrs. Imelda Rocío Guzmán Cervantes possesses a robust set of research skills tailored to her expertise in pharmaceutical regulation and quality control. She excels in developing and implementing regulatory frameworks and quality control processes to ensure the safety and efficacy of pharmaceutical products, medical devices, and vaccines. Her analytical skills include applying various techniques for evaluating product quality and utilizing data analysis tools to interpret research findings effectively. Mrs. Guzmán Cervantes is adept at creating detailed documentation and reports related to regulatory compliance and quality assurance. She is well-versed in international regulatory standards and practices, particularly those established by WHO and PAHO, and integrates these standards into national regulatory systems. Her project management skills enable her to oversee complex research projects, coordinate activities, and ensure adherence to regulatory requirements. Additionally, her research on the impact of regulatory agencies during health crises, such as the COVID-19 pandemic, underscores her commitment to advancing public health safety.

Awards and Recognition

Mrs. Imelda Rocío Guzmán Cervantes has received notable awards and recognition for her distinguished work in pharmaceutical regulation and quality control. Her leadership was pivotal in the recognition of COFEPRIS as a National Regulatory Authority by the World Health Organization (WHO) and the Pan American Health Organization (PAHO). Under her guidance, the National Control Laboratory (CCAYAC) achieved WHO prequalification for drug analysis, reflecting her commitment to maintaining high standards in regulatory practices. Additionally, she has been honored for her contributions as a facilitator and auditor in international regulatory workshops and evaluations, including those for GAVI countries and the Directorate General of Medicines in Peru. These accolades underscore her impactful role in advancing global public health and regulatory standards.

Conclusion

Mrs. Imelda Rocío Guzmán Cervantes’s blend of leadership, regulatory expertise, innovation in public health, and continuous dedication to professional development makes her an ideal candidate for the Health Innovator’s Leadership Award. Her contributions have had a lasting impact on both national and international public health, making her highly deserving of this recognition.

Publications Top Notes

Title: Importance of national regulatory agencies and national control laboratories in the face of the COVID-19 pandemic: Experience of Federal Commission for the Protection against Sanitary Risks (COFEPRIS)
Title (Spanish): Importancia de las agencias reguladoras nacionales y los laboratorios nacionales de control ante la pandemia de COVID-19: experiencia de la Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS)
Authors: Guzmán-Cervantes, I.R., Parra-Hernández, E., Svarch-Pérez, A.E., Zúñiga-Estrada, A., Alcocer-Varela, J.C.
Journal: Vacunas
Year: 2024
Volume: 25
Issue: 3
Pages: 424–427

Andressa Rodrigues dos Santos | Health Professions | Best Researcher Award

Posted on by Shen Awards

Mrs. Andressa Rodrigues dos Santos | Health Professions | Best Researcher Award

Pharmaceutical at Lenoir Vargas Ferreira Hospital Association, United States.

Andressa Rodrigues dos Santos is a pharmaceutical specialist with a focus on oncology, currently working at the Unimed Chapecó Oncology and Hematology Center. She holds a specialization in Clinical Pharmacology from ICTQ and a residency in Oncology from Hospital Regional do Oeste, where she explored CAR-T cell therapy in treating diffuse large B-cell lymphoma. Andressa graduated in Pharmacy from Universidade do Oeste de Santa Catarina, where she was a PROUNI scholarship recipient and involved in research on nutritional labeling and omega-3 supplements. Her professional experience spans clinical oncology pharmacy, pharmaceutical compounding, and analysis. She has contributed to research on the medication therapy for elderly patients with hypertension and diabetes, and she is recognized for her work with the Brazilian Ministry of Health and various health institutions. Her publications include studies on pharmaceutical care and natural product medicine, reflecting her commitment to advancing clinical and pharmaceutical sciences.

Profile

Education🎓

Andressa Rodrigues dos Santos holds a diverse educational background in the field of pharmacy, with a focus on oncology and clinical pharmacology. She completed her undergraduate degree in Pharmacy at the Universidade do Oeste de Santa Catarina (UNOESC) in 2016, where she conducted research on nutritional labeling and omega-3 supplements. Following this, she pursued a specialized residency in Oncology at the Hospital Regional do Oeste (HRO) from 2016 to 2020, where she conducted a systematic review on CAR-T therapy for lymphoma treatment under the guidance of Dr. Daniela Zanini. To further her expertise, she earned a Clinical Pharmacology specialization from the Instituto de Ciencia Tecnologia e Qualidade Industrial (ICTQ) in 2023. Her continuous commitment to professional development is reflected in additional training in areas such as gastrointestinal health, pharmacological assistance, and techniques in pharmaceutical practice.

Professional Experience 🏢

Andressa Rodrigues dos Santos is a dedicated oncology pharmacist currently working at the Centro de Oncologia e Hematologia da Unimed Chapecó. Her professional journey includes significant roles such as a resident pharmacist at Hospital Regional do Oeste, where she specialized in chemotherapy drug handling and pharmaceutical care in oncology. She has also gained experience in clinical analyses during her internship and contributed to both hospital and laboratory settings. Her expertise extends to pharmaceutical manipulation and patient counseling, particularly in managing complex chemotherapy regimens. Her career has been marked by a strong commitment to improving patient outcomes through detailed pharmaceutical care and continuous professional development, including specialization in clinical pharmacology and oncology. This experience has equipped her with a comprehensive understanding of pharmaceutical practices and patient care in oncology, underscoring her contributions to the field.

Research Interests 🔬

Andressa Rodrigues dos Santos is deeply involved in advancing the field of oncology through her specialized research interests. Her work focuses on the pharmacological management of cancer patients, particularly in the context of chemotherapy and advanced therapeutic strategies like CAR-T cell therapy. She has conducted a systematic review on CAR-T therapy for treating diffuse large B-cell lymphoma, highlighting her commitment to exploring innovative treatments and improving patient outcomes. Her research also spans the evaluation of medication therapy in elderly patients with hypertension and diabetes, demonstrating her dedication to optimizing pharmacotherapy in diverse patient populations. With a solid foundation in clinical pharmacology and hands-on experience in pharmaceutical oncology, Andressa aims to contribute to better therapeutic approaches and patient care practices in oncology. Her ongoing research underscores a commitment to bridging clinical practice with cutting-edge scientific advancements in cancer treatment.

Award and Honors

Andressa Rodrigues dos Santos has been recognized for her academic excellence and contributions to the field of pharmacy and oncology. In 2022, she received the “Mérito Estudantil” award from the Universidade do Oeste de Santa Catarina, acknowledging her outstanding academic performance throughout her course. This accolade highlights her commitment to achieving high standards in her education. Additionally, her research efforts have been acknowledged through various projects and funding support, such as her work on the analysis of pharmacotherapy in elderly patients with hypertension and diabetes, funded by the Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina. Her dedication to improving patient care and advancing pharmaceutical practices underscores her significant contributions to her field. These honors reflect her dedication, expertise, and impact on the pharmaceutical and oncology sectors.

Research Skills

Andressa Rodrigues dos Santos demonstrates a robust set of research skills that underscore her expertise in the field of pharmacy, particularly in oncology. Her academic and professional journey reflects a profound capability in conducting systematic reviews, evidenced by her work on CAR-T therapy for diffuse large B-cell lymphoma. Her proficiency extends to clinical research, where she has applied her knowledge to evaluate medication therapy for elderly patients with hypertension and diabetes mellitus. Her experience includes manipulating chemotherapeutic drugs and providing pharmaceutical care in a multidisciplinary setting, showcasing her practical application of theoretical knowledge. Additionally, Andressa’s involvement in various research projects highlights her ability to analyze complex data, contribute to scholarly publications, and engage in collaborative research efforts. Her skills are further complemented by her clinical practice, where she integrates research findings to enhance patient care and treatment outcomes.

Research Contributions and Publications

Andressa Rodrigues dos Santos has demonstrated significant contributions to the field of oncology and clinical pharmacology. Her research is notably focused on the pharmacological management of oncology patients and includes a detailed review of CAR-T cell therapy in treating diffuse large B-cell lymphoma. This work, conducted as part of her residency program, highlights her dedication to advancing therapeutic strategies and improving patient outcomes in oncology.

 

Publications Top Notes 📚

  1. Assistance and Pharmaceutical Care Applied to Elderly Patients with Systemic Arterial Hypertension and Type II Diabetes Mellitus Attended at the Hélio Ortiz Basic Health Unit in the Municipality of Xanxerê
    • Authors: Not specified in the provided information
    • Year: 2018
    • Event: Seminário de Iniciação Científica, Seminário Integrado de Ensino, Pesquisa e Extensão e Mostra Universitária, Xanxerê
  2. Study of Fungal Diversity Originating from Different Exposure Locations
    • Authors: Beal, A. M.; Santos, A. R.; Trizotto, C.; Riva, T. D.; Maciel, C. G.
    • Year: 2017
    • Event: VIII Mostra Universitária, Xanxerê
  3. Natural Products of Plant Origin as a Source of Medicines
    • Authors: No
    • Year: 2017
    • Event: I Semana Acadêmica Integrada dos Cursos de Enfermagem e Farmácia – Prevenção e Segurança do Paciente, Xanxerê
  4. Buffer Solutions: Preparation and Evaluation of Their Efficiency
    • Authors: Tombini, J.; Beal, A. M.; Riva, T. D.; Santos, A. R.; Trizotto, C.
    • Year: 2018
    • Event: Pesquisa e Extensão Unoesc Xanxerê